Darunavir 800 mg tablet approved in the US
1 December 2012. Related: Antiretrovirals.
On 9 November 2012, the FDA approved an 800 mg tablet of darunavir (Prezista).
The Dosage and Administration section of the product label has been changed to:
Treatment-naïve adult patients and treatment-experienced adult patients with no darunavir resistance associated substitutions: 800 mg (one 800 mg tablet or two 400 mg tablets) taken with ritonavir 100 mg once daily and with food.
Source: FDA announcement (9 November 2012)